Back to top
more

DexCom (DXCM)

(Delayed Data from NSDQ)

$69.00 USD

69.00
3,405,133

-0.70 (-1.00%)

Updated Nov 5, 2024 04:00 PM ET

After-Market: $68.91 -0.09 (-0.13%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (86 out of 250)

Industry: Medical - Instruments

Zacks News

John Blank headshot

What Stocks Move After the Stimulus Bill Passes?

The U.S. economy can recover (quicker) with this bill.

Nalak Das headshot

US Government Reaches Deal on Stimulus Package: 5 Top Picks

The U.S. government and Senate reached an agreement to inject $2 trillion of stimulus to boost the U.S. economy amid the coronavirus-induced turmoil.

DexCom (DXCM) Gains As Market Dips: What You Should Know

In the latest trading session, DexCom (DXCM) closed at $209.50, marking a +1.58% move from the previous day.

The Zacks Analyst Blog Highlights: HP, DexCom and Western Digital

The Zacks Analyst Blog Highlights: HP, DexCom and Western Digital

John Blank headshot

No Gatherings of 50 People or More: Global Week Ahead

The struggle arrived from solving this riddle: It is the Travel & Leisure industry buckling completely that is more important than the Fed's surprise Sunday action.

Tirthankar Chakraborty headshot

New Strong Buy Stocks for March 16th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for today:

DexCom (DXCM) Down 3.3% Since Last Earnings Report: Can It Rebound?

DexCom (DXCM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Is DexCom (DXCM) Stock Outpacing Its Medical Peers This Year?

Is (DXCM) Outperforming Other Medical Stocks This Year?

Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?

Sector ETF report for XHE

DexCom (DXCM) Stock Moves -1.89%: What You Should Know

In the latest trading session, DexCom (DXCM) closed at $247.64, marking a -1.89% move from the previous day.

Masimo Inks Deal With Imprivata, Improves Patient Monitoring

Masimo's (MASI) partnership with Imprivata is likely to boost patient outcomes through the integration of Imprivata Medical Device Access into Masimo's Hospital Automation solutions.

Here's Why You Should Retain HMS Holdings (HMSY) Stock Now

HMS Holdings (HMSY) is gaining traction from growing PI and TPM analytical services.

Here's Why You Should Invest in Intuitive Surgical Stock Now

Intuitive Surgical (ISRG) continues to benefit from da Vinci surgical system, strong global foothold and solid recurring revenue base. However, stiff competition remains a woe.

Here's Why You Should Hold on to OPKO Health Stock for Now

OPKO Health (OPK) continues to gain from RAYALDEE and BioReference platforms, and focus on R&D despite operating losses.

Here's Why You Should Invest in Integer Holdings Stock Now

Integer Holdings (ITGR) continues to benefit from portfolio management, strong foothold in the broader MedTech space and rising Non-Medical sales.

Is DexCom (DXCM) Outperforming Other Medical Stocks This Year?

Is (DXCM) Outperforming Other Medical Stocks This Year?

Is Dexcom (DXCM) a Great Growth Stock?

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Dexcom (DXCM).

Insulet Partners With Dexcom for Automated Insulin Delivery

This agreement is a major step forward in Insulet's (PODD) commitment toward bolstering its automated insulin delivery system and providing better clinical outcomes for diabetes patients.

Increased Earnings Estimates Seen for DexCom (DXCM): Can It Move Higher?

DexCom (DXCM) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.

Why DexCom (DXCM) Stock Might be a Great Pick

DexCom (DXCM) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Will DexCom Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor in DexCom.

Can Dental Growth Drive Henry Schein's (HSIC) Q4 Earnings?

Consistent contribution from Henry Schein One is likely to have benefited Henry Schein's (HSIC) Q4 performance.

DexCom (DXCM) Q4 Earnings and Revenues Surpass Estimates

DexCom's (DXCM) fourth-quarter earnings benefit from higher revenues and solid performing Sensor and Transmitter segments.

Baxter (BAX) and COSMED Receive FDA Clearance for Q-NRG+

The latest FDA clearance is likely to boost Baxter's (BAX) Clinical Nutrition segment.

The Zacks Analyst Blog Highlights: Waste Management, TC Energy, Duke Energy, DexCom and Republic Services

The Zacks Analyst Blog Highlights: Waste Management, TC Energy, Duke Energy, DexCom and Republic Services